THNR - Amplify Weight Loss Drug... Analysis | Stock Taper
Logo
Pricing Sign Up Log In

THNR

Amplify Weight Loss Drug & Treatment ETF
Amplify Weight Loss Drug & Treatment ETF • Amplify
$24.84 ▼ -0.80% (-0.20)
Managing Company Amplify
Asset Under Management $4.21M
Inception Date May 21, 2024
Expense Ratio 0.59%
52w High $27.28
52w Low $19.97
Volume 382
Avg Volume 2,586
Asset Class Equity

About Amplify Weight Loss Drug & Treatment ETF

THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.

SECTOR HOLDINGS

Healthcare Healthcare
97.64%
Financial Services Financial Services
2.20%
Cash & Others Cash & Others
0.16%

ASSET ALLOCATION BY REGION

United States flag United States
51.60%
Denmark flag Denmark
13.81%
China flag China
11.50%
Japan flag Japan
10.80%
United Kingdom flag United Kingdom
5.15%
Switzerland flag Switzerland
4.83%
South Korea flag South Korea
1.23%
Other
1.08%

Holdings (Top 20)

NVO

NVO

Novo Nordisk A/S

Weight: 12.72% Shares: 13.61K Value: $535.07K
LLY

LLY

Eli Lilly and Company

Weight: 11.60% Shares: 529 Value: $488.00K
REGN

REGN

Regeneron Pharmaceuticals, Inc.

Weight: 6.63% Shares: 369 Value: $278.78K
AMGN

AMGN

Amgen Inc.

Weight: 6.25% Shares: 749 Value: $262.86K
ARWR

ARWR

Arrowhead Pharmaceuticals, Inc.

Weight: 5.21% Shares: 3.29K Value: $219.21K
AZN

AZN

AstraZeneca PLC

Weight: 5.16% Shares: 1.06K Value: $217.25K
MRK

MRK

Merck & Co., Inc.

Weight: 5.03% Shares: 1.76K Value: $211.49K
PFE

PFE

Pfizer Inc.

Weight: 4.90% Shares: 7.61K Value: $206.20K
ABBV

ABBV

AbbVie Inc.

Weight: 4.49% Shares: 907 Value: $189.14K
VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 2.38% Shares: 2.82K Value: $100.09K
SRRK

SRRK

Scholar Rock Holding Corporation

Weight: 2.36% Shares: 2.00K Value: $99.35K
GPCR

GPCR

Structure Therapeutics Inc.

Weight: 2.20% Shares: 1.74K Value: $92.50K